Clinical Trial Update: Exhaled Nitric Oxide : Biomarker of Acute Respiratory Distress Syndrome

View source ↗

Summary

A completed clinical trial evaluated whether exhaled nitric oxide could serve as a biomarker for acute respiratory distress syndrome (ARDS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: University Hospital, Grenoble | Conditions: ARDS, Human, Nitric Oxyde | Status: COMPLETED